🇺🇸 FDA
Pipeline program

Valbenazine Oral Capsule

STUDY20221555

Approved small_molecule terminated

Quick answer

Valbenazine Oral Capsule for Tardive Dyskinesia is a Approved program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
NEUROCRINE BIOSCIENCES INC
Indication
Tardive Dyskinesia
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials